A FIH Study to Assess the Safety and Tolerability of NS Intravenous NS101 Infusion

Clinical trial NCT05143463 · COMPLETED

Trial details

NCT number: NCT05143463
Sponsor: Neuracle Science Co., LTD.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neurodegenerative Diseases

Start date: 2021-11-04
Primary completion: 2022-08-19
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.